Biofilm bacteria: formation and comparative susceptibility to antibiotics
about
The small regulatory RNA molecule MicA is involved in Salmonella enterica serovar Typhimurium biofilm formationHigh-throughput metal susceptibility testing of microbial biofilmsPrevalence of virulence factors in Staphylococcus intermedius isolates from dogs and pigeonsIntrigues of biofilm: A perspective in veterinary medicine.Pasteurella multocida non-native joint infection after a dog lick: A case report describing a complicated two-stage revision and a comprehensive review of the literatureBacterial biofilms: their importance in animal health and public healthGrowing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistanceCoagulase-negative staphylococci.Characterization and comparison of biofilm development by pathogenic and commensal isolates of Histophilus somni.Brominated furanones inhibit biofilm formation by Salmonella enterica serovar Typhimurium.Photodynamic therapy of antibiotic-resistant biofilms in a maxillary sinus model.Specific involvement of pilus type 2a in biofilm formation in group B Streptococcus.Damage of Streptococcus mutans biofilms by carolacton, a secondary metabolite from the myxobacterium Sorangium cellulosum.Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.Burn wound infections.Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa.Characterization of multi-drug tolerant persister cells in Streptococcus suis.Competence-dependent endogenous DNA rearrangement and uptake of extracellular DNA give a natural variant of Streptococcus mutans without biofilm formation.Local gentamicin delivery from resorbable viscous hydrogels is therapeutically effective.CORR Insights®: Local gentamicin delivery from resorbable viscous hydrogels is therapeutically effectiveFusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent.Pluronics-Formulated Farnesol Promotes Efficient Killing and Demonstrates Novel Interactions with Streptococcus mutans Biofilms.Unravelling the Bacterial Vaginosis-Associated Biofilm: A Multiplex Gardnerella vaginalis and Atopobium vaginae Fluorescence In Situ Hybridization Assay Using Peptide Nucleic Acid Probes.Characterization of Biofilm Formation in [Pasteurella] pneumotropica and [Actinobacillus] muris Isolates of Mouse OriginThe Effect of pH on the Extracellular Matrix and Biofilms.Biofilm production by multiresistant Corynebacterium striatum associated with nosocomial outbreakBiofilm models of polymicrobial infection.In Vitro Effects of Polyphosphate against Prevotella intermedia in Planktonic Phase and BiofilmBiofilm formation by group a streptococci: is there a relationship with treatment failure?Auxotrophic Actinobacillus pleurpneumoniae grows in multispecies biofilms without the need for nicotinamide-adenine dinucleotide (NAD) supplementationHypothetical protein Avin_16040 as the S-layer protein of Azotobacter vinelandii and its involvement in plant root surface attachment.CORR Insights(®): D-amino acid inhibits biofilm but not new bone formation in an ovine model.Targeted delivery of vancomycin to Staphylococcus epidermidis biofilms using a fibrinogen-derived peptide.The presence of the putative Gardnerella vaginalis sialidase A gene in vaginal specimens is associated with bacterial vaginosis biofilmHuman Granulocyte Macrophage Colony-Stimulating Factor Enhances Antibiotic Susceptibility of Pseudomonas aeruginosa Persister Cells.In Vitro Efficacy of Nonantibiotic Treatments on Biofilm Disruption of Gram-Negative Pathogens and an In Vivo Model of Infectious Endometritis Utilizing Isolates from the Equine Uterus.Evaluation of humoral immunity and protective efficacy of biofilm producing Staphylococcus aureus bacterin-toxoid prepared from a bovine mastitis isolate in rabbit.In Vitro Approach for Identification of the Most Effective Agents for Antimicrobial Lock Therapy in the Treatment of Intravascular Catheter-Related Infections Caused by Staphylococcus aureus.ZapA, a virulence factor in a rat model of Proteus mirabilis-induced acute and chronic prostatitis
P2860
Q21263115-F54DF73B-853D-4852-B4AC-3058BF4B2FE7Q24815163-61622717-72CB-42DC-BE55-DE4F6D91B08BQ25257528-F569E01C-BA28-4C01-B466-1DC61C9BFB7BQ26751336-55A0BE25-0160-45BF-B42D-124BBAF86D97Q26781497-44E3E148-033E-4AFD-AA9C-2B1FA97A5951Q27004028-F30BE026-5613-46D1-9FA1-502C524066FBQ28472874-088ACD3F-D799-4FAE-9ED4-1739B8B74E6AQ30401758-565F5667-8BBC-483A-99CF-BB66F025C7C3Q30443516-AC92A32B-BE77-4FEF-8D4F-F6A01F1E9908Q33369375-83F0F0FC-1337-48A4-A5C3-054349E745C0Q33390557-F57840FA-5B27-4818-A8E1-08E37FABB364Q33532629-17FDD652-8029-4F6A-A092-C441B370478AQ33640738-C4936A4D-C571-44DD-8576-FE7D75DEBE1BQ34073568-EF5B510A-4203-4C25-ABE6-BB61C0189D86Q34647310-2CF5BAEE-12C1-4680-B013-F35663CE40CBQ35050946-1B0EBAAD-99D6-451F-8457-AE54D289A882Q35109394-41AD6744-BA88-45F9-8889-60C0846854CFQ35178525-06C3303D-7481-4C8F-BCE5-978FA55FD55AQ35274076-F43E6231-1DDF-446D-827E-64D284844622Q35335238-F5E8588C-4566-44A3-8BFF-C2E312830B40Q35335418-0E946BEE-4869-41D8-9205-B0DF0668997EQ35653429-83D84121-6B51-495D-AF23-E4EB27609E68Q35723178-5FFC1AA2-E4B5-4B62-B512-8D4AB9A45998Q35754773-321E74B4-C9A7-4A85-95B2-B3E1628C32E4Q35796681-B2614707-806B-4679-A45F-70D35739C0E3Q35802405-F1A764E8-E960-4702-A7C8-4F00FB17B715Q35810694-D5E270CA-44CB-418F-ADE4-7F63A289C49DQ35848074-A2495887-B201-42DC-93FC-EFF8CACFBE38Q35848975-358013C1-99E9-4200-AFB8-127765B2FFE6Q35922186-95B51DD3-F0E7-4134-BA49-C5D9D49BC3BDQ36062674-282EBAB5-4DB1-4E9B-AFFB-28C94206F2D5Q36119566-9D71CE3D-53E3-424E-BD95-87654FA99141Q36226278-81DADFC1-85E2-4536-9A78-794CD090AE76Q36289983-22CD261F-320D-4F1D-A889-5D0FD76AF1E6Q36291619-FDFFBA81-DD3F-4822-B117-D10F027CF5FCQ36329466-18FA6F52-00AE-4396-8193-432434D3ACEBQ36620962-CB1283EB-6126-4A25-AAE9-D4D672EBA2CFQ36680357-F637F475-8412-4B32-B72C-A4771792970AQ36888073-5A89A414-E3BA-49FA-9D6C-5CE80E1FFE53Q36949968-653AD730-CDE2-4D6C-83BC-683619BE7BF7
P2860
Biofilm bacteria: formation and comparative susceptibility to antibiotics
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Biofilm bacteria: formation and comparative susceptibility to antibiotics
@ast
Biofilm bacteria: formation and comparative susceptibility to antibiotics
@en
type
label
Biofilm bacteria: formation and comparative susceptibility to antibiotics
@ast
Biofilm bacteria: formation and comparative susceptibility to antibiotics
@en
prefLabel
Biofilm bacteria: formation and comparative susceptibility to antibiotics
@ast
Biofilm bacteria: formation and comparative susceptibility to antibiotics
@en
P2093
P2860
P1476
Biofilm bacteria: formation and comparative susceptibility to antibiotics
@en
P2093
Andre G Buret
Douglas W Morck
Howard Ceri
Merle E Olson
Ronald R Read
P2860
P577
2002-04-01T00:00:00Z